Netherlocks partial stroke system meets SIL 3

Published: 29-Apr-2010
Manufacturing

According to FMEDA report by Exida, the Netherlocks partial stoke system FAITH (Fail Action Integrity Test Handling) is very reliable

The FMEDA report showed the Netherlocks partial stoke system FAITH (Fail Action Integrity Test Handling) to be very reliable, with 0 Fail Safe Detected, Fail Safe Undetected and Fail Dangerous Detected conditions recorded from the tests. For most cases, the FAITH is suitable for use in SIL3 applications.

The FAITH system makes it possible to carry out a manually initiated partial stroke test on ESD (Emergency Shut Down) valves during normal operation, without interrupting process flow. It limits, with mechanical stops, the angle of the stroke of the valve-actuator combination to a set percentage – ensuring the ESD valve ‘works’, without actually shutting down the operation. By operating mechanically rather than relying on electronic contacts or signals, reliability and simplicity is maximised.

An FMEDA (Failure Modes, Effects, and Diagnostic Analysis) assessment has been carried out by Exida on Netherlocks’ FAITH system. The product was subject to a thorough examination according to IEC 61508 to determine Probability of Failure on Demand (PFD) statistics for this device. The failure rates of the FAITH System must be added to the failure rates of the valve-actuator combination when determining the PFD AVG and Safe Failure Fraction (SFF) for the final element.

More details, a summary and the report itself are available to customers upon request from sales@netherlocks.com or at www.netherlocks.com.
See more

You may also like

Manufacturing

Two leading valve operation brands merge to form Sofis

Read more
Netherlocks and Smith Flow Control reveal new corporate identity

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    Overcoming the hurdles of strategic market expansion Ramprasad Kaparaboyena, Regulatory Affairs Manager and QP for Pharmacovigilance at Gaelic Laboratories, discusses how to overcome the challenges of expanding your pharma market into new global regions
  2. Vetter Pharma to build new manufacturing site in Germany as part of €1.5bn global expansion plan The company has submitted a building permit application for a new commercial manufacturing facility in Saarland, Germany, with construction set to begin in Q2 2026 and operations planned for 2031
  3. Drug-loaded pellets: unlocking flexible oral dosage design with modern pelletisation technologies Produced using advanced extrusion–spheronisation technologies such as GEA’s NICA systems, drug-loaded pellets are gaining traction as a flexible and scalable oral solid dosage platform that enhances release control, patient outcomes and manufacturing efficiency
  4. LabIndex - Sourcing solutions powered by a network of world-class suppliers Labtex states: "Using our experience and negotiating power, we can speedily source and procure virtually any type of laboratory equipment or consumables at competitive prices."
  5. New thermal inkjet printer expands AM Labels’ coding portfolio M2 system delivers high resolution variable data printing at production-line speeds

Upcoming event

High Shear = Mixing Success

19 February 2026 | Virtual See all

You may also like

Manufacturing

Two leading valve operation brands merge to form Sofis

Netherlocks and Smith Flow Control reveal new corporate identity
Manufacturing

Bracco enters cell therapy manufacturing with microbubble-based cell selection technology

Bracco Imaging is expanding into cell therapy manufacturing with a bead-free cell selection and activation technology based on its clinically validated microbubble platform
Manufacturing

New manufacturing line from Adragos granted regulatory approval from Swissmedic

The approval of the new, state-of-the-art facility follows a comprehensive modernisation programme in 2024/2025 that has focussed on ensuring the future-readiness of the plant
Manufacturing

Freudenberg Medical launches new hydrophilic coating LUBRITEQ

The launch comes alongside a comprehensive suite of associated development and manufacturing services designed to remove commercial barriers and enable long-term, trust-based partnerships
Manufacturing

The REACTEX range - cutting-edge components, unmatched precision

Utilising cutting-edge components from leading UK and German manufacturers, the REACTEX range of interchangeable glass reactors offer the following:
Manufacturing

Drug-loaded pellets: unlocking flexible oral dosage design with modern pelletisation technologies

Produced using advanced extrusion–spheronisation technologies such as GEA’s NICA systems, drug-loaded pellets are gaining traction as a flexible and scalable oral solid dosage platform that enhances release control, patient outcomes and manufacturing efficiency
Manufacturing

Vetter Pharma to build new manufacturing site in Germany as part of €1.5bn global expansion plan

The company has submitted a building permit application for a new commercial manufacturing facility in Saarland, Germany, with construction set to begin in Q2 2026 and operations planned for 2031
Subscribe now